Forte Biosciences, Inc. (FBRX) Operating income 2016–2025
Forte Biosciences, Inc. (FBRX) annual operating income history from SEC filings — each fiscal year as reported.
-$70.7MFY2025 · since FY2016: -$31.7M → -$70.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.7M | -93.0% |
| FY2024 | -$36.6M | -12.7% |
| FY2023 | -$32.5M | -133.8% |
| FY2022 | -$13.9M | +35.3% |
| FY2021 | -$21.5M | +53.6% |
| FY2020 | -$46.3M | -1038.8% |
| FY2019 | -$4.1M | +91.1% |
| FY2018 | -$45.9M | -21.9% |
| FY2017 | -$37.6M | -18.7% |
| FY2016 | -$31.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice